MilliPROBE Detects Biopharmaceutical Microbial Contamination in Hours
go back to news archives | The MilliPROBE system is the first solution of its kind for biopharmaceutical manufacturing. It combines Millipore's leading, industry-accepted sample prep methodologies with Gen-Probe's advanced, proven nucleic acid technologies to deliver both speed and sensitivity in one microbial screening tool. |
The MilliPROBE system uses Real-Time Transcription-Mediated Amplification (TMA) technology to detect targeted microbial contamination within hours compared to the days or weeks usually required to generate results using traditional culture-based technology. Faster detection allows biopharmaceutical manufacturers to take corrective action earlier in the production process, which reduces downstream processing risks, optimizes product yields, and improves final product quality. These improvements may result in better operational efficiency and lower manufacturing cost for product manufacturers. |
NOTE: This item is from our 'historic' database and
may contain information which is not up to date.
Source : Millipore Corp View Company Information
Posted on June 9, 2008
LATEST MICROBIOLOGY NEWS
-
AOAC Validated iQ-Check Vibrio PCR Kit
01 Apr 2025 -
AI-Powered Precision For Colony Counting
27 Mar 2025
MICROBIOLOGY EVENTS
-
Mycotoxin Detection and Analysis: Strategies to Support Your Testing Program
3 Apr 2025 -
15th Conference of The World Mycotoxin Forum® – WMFmeetsSalzburg
7 Apr 2025 -
ESCMID European Congress of Clinical Microbiology and Infectious Diseases
11 Apr 2025 -
IBQC 2025
14 Apr 2025 -
IFU Technical Workshop 2025
15 Apr 2025 -
Validation of Water Systems for Microbial Control
23 Apr 2025 -
USP Chapter <86> and the Move to Recombinant Methods
29 Apr 2025 -
Free Expert Webinar: Advancing Drinking Water Microbiology Testing Compliance & Efficiency
29 Apr 2025 -
British Society For Microbial Technology 40th Anniversary Microbiology Conference
15 May 2025 -
Sampling and Microbial Testing of Water and Data Trending
20 May 2025